The quick answer
Botox Cosmetic and Xeomin are botulinum toxin type A products with different formulations. Xeomin lacks the accessory complexing proteins present in Botox. That distinction alone does not prove a better result, longer duration or immunity from treatment resistance.
At a glance
| Detail | Botox Cosmetic | Xeomin |
|---|---|---|
| Drug name | OnabotulinumtoxinA | IncobotulinumtoxinA |
| Complexing proteins | Includes associated proteins | Without accessory complexing proteins |
| Units | Product-specific; not interchangeable | Product-specific; not interchangeable |
| What to compare | Area, prescribed plan and final total | Area, prescribed plan and final total |
What ‘without complexing proteins’ means
Xeomin's formulation contains the active neurotoxin without accessory complexing proteins. Botox has a different formulation. ‘Purified,’ ‘clean’ and ‘premium’ are not substitutes for explaining what that difference means for a particular patient.
Our editorial take: ask for a clinical reason for the recommendation. Formulation is one consideration; a sales description alone cannot establish superior safety, appearance or duration.
Does Xeomin prevent Botox resistance?
Do not read protein-related marketing as a promise that resistance cannot occur. A disappointing result needs a clinician's review of the actual product, dose, placement, timing and treatment history before assuming antibody-related resistance.
Tell the doctor about previous toxin brands, dates and responses. Switching products or adding injections without that assessment may not address why the result differed from your expectations.
Compare the total plan, not an identical unit number
The labels state that units are not interchangeable with other toxin products. Matching two advertisements by unit count does not establish equivalent treatment. Ask the clinician to explain the plan for the same intended area and effect.
Confirm whether the clinic actually stocks both products and whether consultation, VAT, review and any later adjustments are included. This guide does not have a verified brand-matched Seoul price comparison and does not rank the two by cost.
Safety and your previous treatment history
Tell the doctor which toxin you last received, when and where it was injected, any side effects, and your medicines and medical conditions. Brand choice alone does not determine suitability.
Product labels warn about effects spreading beyond the injection site. Seek urgent medical help for difficulty breathing, swallowing or speaking. Local effects can include eyelid droop; discuss the risks for your intended area with the injector.
What to confirm at a Korean clinic
The product examples and prescribing information cited here are US references. They do not establish Korean approval, local availability or an approved use in Korea. Ask the treating doctor to confirm the exact locally supplied product and whether the proposed treatment is within its Korean labeling.
Get the product name, quantity, area, VAT, consultation and follow-up terms in writing. A menu category such as ‘imported filler’ or ‘premium Botox’ is not a product specification. Keep a copy of your treatment record and the clinic's aftercare contact before leaving Seoul.
Questions to take to the clinic
- Why do you recommend this formulation for my history and goal?
- Which exact product, area and dose are in the written plan?
- If previous treatment seemed ineffective, what will you assess before switching brands?
- What is the complete fee and the review policy?
Common questions
Is Xeomin safer because it has fewer proteins?
The formulation difference does not by itself establish that Xeomin is safer for you. Both products have contraindications and serious warnings; suitability requires medical assessment.
Can I switch from Botox to Xeomin?
A clinician can assess whether a switch is appropriate. Share your previous treatment dates, product, dose if known, results and adverse effects before agreeing to a new plan.
Does Xeomin last longer than Botox?
This guide establishes no universal duration advantage. Ask about the expected course for your area and prescribed plan rather than relying on a brand-wide promise.
Sources and research notes (3)
This is sourced editorial research, not a hands-on treatment review or an independent clinical trial. Device specifications and manufacturer claims are distinguished from human study findings. Study size, protocol and comparison groups limit what can be concluded. The practical trade-offs labelled as our editorial take are interpretations, not proven superiority. Medical suitability and travel clearance require the treating clinician's assessment.
Have a quote already?
Match the product, dose and treatment area, then see how the total compares with Korean event prices.
Check my quote